Literature DB >> 10625141

The diagnostic value of digital rectal examination in primary care screening for prostate cancer: a meta-analysis.

A Hoogendam1, F Buntinx, H C de Vet.   

Abstract

OBJECTIVE: This systematic review examines the diagnostic value of the digital rectal examination (DRE) for the diagnosis of prostate cancer.
METHOD: Only studies relating to unselected populations and using either biopsy or surgery as the reference standard were included. The methodological quality of the studies was used in an attempt to explain differences between studies.
RESULTS: Fourteen studies were eligible for selection, of which five complied with the predetermined list of 'good-quality' requirements. Between study heterogeneity was high, even within the group of high-quality studies, and could not be explained by the registered indicators of methodological quality.
CONCLUSIONS: In this setting, the DRE appears to be a test with a high specificity and negative predictive value, but a low sensitivity and positive predictive value. Neither a positive nor a negative test result is sufficient to enable conclusions without further confirmation.

Entities:  

Mesh:

Year:  1999        PMID: 10625141     DOI: 10.1093/fampra/16.6.621

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  17 in total

1.  Systematic reviews of diagnostic research. Considerations about assessment and incorporation of methodological quality.

Authors:  H C de Vet; T van der Weijden; J W Muris; J Heyrman; F Buntinx; J A Knottnerus
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

Review 2.  Variation of a test's sensitivity and specificity with disease prevalence.

Authors:  Mariska M G Leeflang; Anne W S Rutjes; Johannes B Reitsma; Lotty Hooft; Patrick M M Bossuyt
Journal:  CMAJ       Date:  2013-06-24       Impact factor: 8.262

Review 3.  [Prostate biopsy. Update for indication, procedure, and future developments].

Authors:  S Machtens; A Roosen; C G Stief; M C Truß
Journal:  Urologe A       Date:  2014-07       Impact factor: 0.639

4.  Profiling of circulating microRNAs for prostate cancer biomarker discovery.

Authors:  Christa Haldrup; Nobuyoshi Kosaka; Takahiro Ochiya; Michael Borre; Soren Høyer; Torben F Orntoft; Karina D Sorensen
Journal:  Drug Deliv Transl Res       Date:  2014-02       Impact factor: 4.617

Review 5.  Digital Rectal Examination for Prostate Cancer Screening in Primary Care: A Systematic Review and Meta-Analysis.

Authors:  Leen Naji; Harkanwal Randhawa; Zahra Sohani; Brittany Dennis; Deanna Lautenbach; Owen Kavanagh; Monica Bawor; Laura Banfield; Jason Profetto
Journal:  Ann Fam Med       Date:  2018-03       Impact factor: 5.166

Review 6.  [Imaging modalities for primary diagnosis and staging of prostate cancer].

Authors:  U G Mueller-Lisse; K Miller
Journal:  Urologe A       Date:  2010-02       Impact factor: 0.639

7.  Prostate-specific antigen, digital rectal examination and transrectal ultrasonography: a meta-analysis for this diagnostic triad of prostate cancer in symptomatic korean men.

Authors:  Jae Mann Song; Chun Bae Kim; Hyun Chul Chung; Robert L Kane
Journal:  Yonsei Med J       Date:  2005-06-30       Impact factor: 2.759

8.  Transrectal electrical impedance tomography of the prostate: spatially coregistered pathological findings for prostate cancer detection.

Authors:  Yuqing Wan; Andrea Borsic; John Heaney; John Seigne; Alan Schned; Michael Baker; Shaun Wason; Alex Hartov; Ryan Halter
Journal:  Med Phys       Date:  2013-06       Impact factor: 4.071

9.  The diagnostic value of macroscopic haematuria for the diagnosis of urological cancer in general practice.

Authors:  Rudi Bruyninckx; Frank Buntinx; Bert Aertgeerts; Viviane Van Casteren
Journal:  Br J Gen Pract       Date:  2003-01       Impact factor: 5.386

10.  Incorporating a biopsy needle as an electrode in transrectal electrical impedance imaging.

Authors:  Yuqing Wan; Andrea Borsic; Alex Hartov; Ryan Halter
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.